chrisvoncsefalvay/vaers-outcomes huggingface dataset:
area on arm where shot was given was red & hot for about a week p/vax given;area was sore for about a month & a half p/shot was given;
patient's left arm is very painful with shooting pains since his HPV injection 7/25/19. This was his 2nd HPV, first one didn't give any trouble. Mother notes that he complains of pain daily, this is unusual for him. Pain is at location of injection and in armpit. Using ibuprofen with good temporary relief. Doesn't feel like his pain is improving at all.
Family reports that patient had her 2nd dose of COVID-19 vaccine on 4/1, approximately 3 weeks after her first dose.  Patient had one week history of "allergy type" symptoms.  Evening of 4/1 developed "GI symptoms and diarrhea".  Morning of 4/2 her "neighbor came by to check on her and she stated that she was not feeling very well last night but thought she just needed some Gatorade of something...He stated that as he gave her the alka-Seltzer he told her that there was aspirin in it which apparently she has an allergy to.  He stated that her response was I should be fine I do not think I'm that allergic to aspirin...5 to 10 minutes later she started to have some issues...Patient stated to her neighbor that she was having a hard time breathing and thought she needed to go to the hospital, and that maybe she was more allergic to the aspirin than she had thought...Over the 15 miles between her house and the hospital patient condition deteriorated to the point where they arrived at the hospital she is in full cardiac arrest...given ACLS protocol including epinephrine and was intubated."  "They achieved ROSC after approximately 10 minutes."  Patient was then flown, MT emergency department to Hospital.  Patient was cared for in the ICU.  Patient herniated her brain the night of 4/5-4/6.  "After meeting the clinical and imaging criteria at 1605 on 4/6/2021 she was declared brain dead.  Medical team suggests that patient had Samter's Triad/Triad Asthma with history of asthma, nasal polyps and allergy to aspirin.  Anaphylaxis secondary to ingestion of aspirin via Alka-Seltzer.
Nausea and chills starting about 12 hours post injection, lasting a few hours. Fatigue and muscle fatigue the day after injection lasting into the second day after injection (today).
Information has been received from a physician concerning a 4 year old male with a history of recurrent tonsillitis and no known drug reactions/allergies who on 07/23/2001 was vaccinated with a dose of varicella virus vaccine live.  There was no concomitant medication.  On 02/10/2005 vesicles began erupting.  On 02/11/2004 the patient was seen in the office with less than 25 vesicles.  Unspecified medical attention was sought.  Treatment included diphenhydramine hydrochloride as the occasion required.  There was no product quality complaint involved.  Additional information has been requested.
Client called to report she developed welts over her legs and torso within the first day after vaccination and she continues to have charley horses in the back of her legs and a swollen knee. She did not have blood clots but is going to see a neurologist for follow up.
Initial report received from a consumer on 17 November 2010. A female patient, with a birth date of 15 January 1952, received on an unknown date in 2009 (reported as last year) an injection site (route and site not reported) of INFLUENZA VACCINE, lot number not reported. The patient had a history of shingles and has had ongoing neuralgia. She had no illness at the time of vaccination and received a shingles vaccine prior to the FLUZONE but did not know how long before receiving flu vaccine. The patient's concomitant medications were unknown. On an unknown date last year, the patient developed breathing difficulty, headache, and extreme tiredness for at least three months after the vaccination. The patient was seen by a physician for treatment. The patient reported that the doctor did not think the reactions were related to last year's (2009) flu vaccine. The outcome was reported as recovered. Documents held by sender: None.
Area in armpit became tender and started to swell, spread into left breast, chest and neck area. Call primary care doctor and told to take Benadryl and Motrin, go to ER if worse. Did go to ER, received IV steroids, Benadryl and pain meds. Discharged and told to see primary care next day. Did see primary care and given more pain meds, told to continue with steroids call him on Monday 11/22/2010.
sweat; feeling lousy; Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweat), MALAISE (feeling lousy), CHILLS (Chills) and PYREXIA (fever) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweat), MALAISE (feeling lousy), CHILLS (Chills) and PYREXIA (fever). At the time of the report, HYPERHIDROSIS (sweat), MALAISE (feeling lousy), CHILLS (Chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient was feeling lousy, chills, fever, sweating at about 2 am in the morning.   No treatment medications provided by the reporter.
Case number PHEH2011US04301 is an initial spontaneous report from a health care professional on 15 Sep 2011 and a follow up information received from the health care professional on 04 Oct 2011. This report refers to 14-year-old male child. He was given only the MenA powder component of MENVEO (batch number: A10061) reconstituted with a sterile diluent instead of MenCYW-135 component, intramuscularly into his left deltoid on 13 Sep 2011. No other adverse reaction was reported. It was also reported that he has tolerated the vaccine in the past. Follow up information received from the physician on 04 Oct 2011: Updated age of the patient, batch number and site of vaccination.
Looks like cellulitis; Injection site swollen; Injection site red; Arm was just sore; A spontaneous report was received from a consumer concerning a 82-year old, female, mother who received Moderna's COVID-19 vaccine and experienced sore arm, red and swollen injection site and looks like cellulitis.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 10 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 10 Jan 2021, after receiving the vaccine the patient's arm was sore. On 19 Jan 2021, the injection site is all red and swollen, looks like cellulitis. No treatment for events.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The outcome for the events was unknown.; Reporter's Comments: This case concerns an 82-year-old female patient, who experienced a serious unexpected event of cellulitis, and non- serious expected event of pain in extremity, injection site swelling, and injection site erythema. The event of pain in extremity occurred 1 day (same day) after first dose of mRNA-1273, lot # 039K20A. The event of cellulitis, injection site swelling, and injection site erythema occurred 10 days after first dose of mRNA-1273, lot # 039K20A. Treatment details were not provided. Based on the current available information and temporal association between the use of the product and onset of the events a causal relationship cannot be excluded.
Fever, sore arm, tired, headache, and palpitations.  No treatment was sought by the patient.
ACCORDING TO PATIENT, A WEEK AFTER RECEVING MODERNA VACCINE, HE FELT A SUDDEN CHEST PAIN. HE IMMEDIATELY WENT TO ED.   THE SYMPTOMS RESOLVED A FEW DAYS LATER.
PPV administered @ 3 PM.  By 6 PM pt. reports arm swollen and very painful.  By 9 PM pt. reports she felt feverish, chills, vomited, diaphoretic. Seen by PCP 11/24/08.  Prescribed 6 day course of steroids to reduce inflammation and swelling.  Pt. reports each day the arm is improving.  Last conversation with patient 11/26/08.
This spontaneous report as received on 02-MAR-2017 from a female healthcare worker (Not further specified if a healthcare professional), refers to 10 patients (age and gender not reported) who received unspecified doses in VARIVAX (Lot number M033905, expiration date 20-JUL-2018) immunization series that were improperly stored. The site and route of VARIVAX administration were not reported. The vaccinations occurred between 22-FEB-2017 and 01-MAR-2017. The vaccines were exposed to temperature of 18.5F (Fahrenheit) for a time frame of 5.3 hours. There were no previous temperature excursions reported. The temperature excursion was recorded by a data logger. The patients' pertinent medical history, concomitant medications and drug allergies were not reported. It was further specified that on 22-FEB-2017, this patient (age and gender not reported) received administration of VARIVAX. No adverse effects were reported. There was no product quality complaint involved. No further information was provided. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA001788.
Mild to moderate dizziness and feeling of being off-balance and mild headache on left side of head began 16 days after vaccine #2.  As of today (36 days after vaccine #2), the feeling of dizziness and off-balance persists; the headache did not persist.  I went to my Ear Nose and Throat (ENT) doctor on April 20 (3 days after onset of symptoms) to rule out sinus infection.  ENT did a full workup, including hearing test and nasal endoscopy.  He did not see any sinus infection and he diagnosed my condition as "vestibular migraine."   I don't believe this diagnosis is correct because I have no persistent headache.
Pt developed swelling and redness at the site of injection in left thigh (was treated with ibuprofen) for low-grade fever, 24 hours, post vax.
Initial report received from a health care professional on 08 May 2013. A 27-yearold pregnant female patient, had received first intramuscular dose of ADCEL vaccine (Lot number: C4366AA in right deltoid) on 08 May 2013. Patient's last menstrual period was reported on 23 October 2012. The estimated date of delivery was reported as 31 July 2013. As of 08 May 2013, the patient had not experienced any adverse event. The patient's health during pregnancy, concomitant medications, medical history and risk factors were not reported. Documents held by sender: none.
Administered a vaccine more than 12 hours after puncture/ vial is not discarded after 12 hours and a dose is inadvertently administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered a vaccine more than 12 hours after puncture/ vial is not discarded after 12 hours and a dose is inadvertently administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a vaccine more than 12 hours after puncture/ vial is not discarded after 12 hours and a dose is inadvertently administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered a vaccine more than 12 hours after puncture/ vial is not discarded after 12 hours and a dose is inadvertently administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
Sharp, stabbing pain in middle of chest with every breath. The deeper the breath, the sharper the pain. Pain was severe in morning, first noticed around 4 a.m. and continued to be severe throughout the morning but very gradually eased up to moderate pain by afternoon. Now at 7 p.m., the pain is very slight, barely noticeable. I will call my doctor tomorrow to get it checked since I'm concerned about my heart, or it may or may not be related.
Temperature unknown. Symptoms include, wheezing, runny nose, difficulty breathing through nostrils, time course - ongoing following administration of FLUMIST. LAN. Symptoms are on a daily bases to this present day, although the runny nose has ended, medications for bacterial infections and allergies given; neither resolved the symptoms.
Extreme discomfort and swelling in left armpit. Muscle and joint soreness and tenderness in left arm and chest.
Headache lasting more than 24 hours, chills, soreness and inflammation in vaccine site beginning on 2/11/21 Rash beginning on 2/12 on opposite arm  from vaccine site  spreading to my neck, throat and bottom of my feet.
Presented from Rehab after testing positive for COVID-19. Initially patient was asymptomatic, but overnight on first night increased to 2L O2 oxygen requirement. Additionally bilateral infiltrates noted on CXR and procalcitonin elevated, suspected worsening COVID-19 pneumonia. Patient was placed on 5 day course of ceftriaxone, initially on doxy but stopped after negative MRSA screen and viral panel for atypicals. Additionally was placed on Decadron 6mg x10 days and Remdesivir x5 days for COVID management.
Tongue tingling sensation. BP 154/93 (pulse 96), O2 sat 98%. F/U BP 135/83 (pulse 87). Patient felt like her reaction was more anxiety related.
4 days after receiving first dose, tightness in throat and difficulty breathing. Feeling of swollen throat. Headache and fever.
Initial report was received on 08/24/2005 from a healthcare professional.  A six year old female child was vaccinated with Daptacel in the left arm, and Ipol, on 08/22/2005.  The following day the patient experienced left arm swelling and redness the length of the arm, the areas was hot to touch and tender.  It was not specified whether the events occurred at the site of the vaccination.  She was subsequently treated with Tylenol and Benadryl.  the patient had not recovered from these events at the time of this report.
Redness and swelling at site approx 12 hrs later. Ice and BENADRYL.
Muscle Aches, R arm swelling, Fever to 103, few hours of confusion
History of back pain this summer, 9/1/16 was playing cello for a few hours, developed sharp back pain without radiation, and tingling distal to knee. Entire left leg was numb to touch and not able to move ankle. Was hospitalized x 3 days, followed by neuro, leg remains numb below knee. Receiving physical therapy.
Information has been received from a pharmacist concerning a female who was vaccinated with Zostavax (Oka/Merck) (lot658082/0744U).  On the second day after vaccination, the patient developed a dark red, hot to touch and itchy, 3 inch injection site reaction.  On day 3 the redness decreased but the site became lumpy.  The patient was treated with TYLENOL and cool compresses.  This is one report of several reports received from the same source.  Additional information has been requested.
Sore throat; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283 and expiry date: unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated that the day after he got the injection, he started to get a sore throat on 16Jan2021. He assumed it was a side effect and the sore throat has not gotten better. It was possibly somewhat worse and was debilitating. He wanted to know if this was a side effect that will go away and what he can do to help it go away. Outcome of the event was not recovered.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 18-OCT-2017, the patient was vaccinated with an improperly stored dose of PROQUAD lot # M048201, expiration date 05-JUN-2018 or lot # N008826, expiration date 12-SEP-2018 (dose, vaccination site and route of administration were not reported) for prophylaxis. No adverse effects were reported. Administered dose of vaccine underwent a temperature excursion from 6 degrees Fahrenheit to 14 degrees Fahrenheit for 30 minutes. Digital data logger was involved. There were no previous temperature excursions reported. This is one of three reports received from the same reporter.; Sender's Comments: US-009507513-1711USA005336: US-009507513-1711USA009219:
Patient went to ER 6/28/21 with complaints of chest tightness that began 6/27/21. Discharged home. Went back to ER twice on 7/1/2021 with body aches, fever, chest pain, abdominal pain, diarrhea.  Diagnosed with acute pulmonary embolism, enteritis,
On 6-15-16 patient noted tingling in face. On 6-22-16 went to the ER. On 6-23-16 saw Cardiology. On 6-27-16 saw Primary Care physician. On 6-28-16 saw neurology to rule out Guillain-Barre syndrome.
Felt tingling on my left side of my scalp Saturday afternoon about 3pm, painful to touch.  By Monday the headache was persistent and never quite goes away. Feels like a low-grade persistent headache that is never going away. Occasionally feel a sharp pain on my scalp as well.  Tuesday noticed rashes had broken out on my left cheek, and above my left eye underneath the left brow.  Rash has now spread to the left side of my forehead too as of Wednesday
Redness and swelling at HIB injection site after 4-5 Hours. Swelling, redness and crying subsided Two hours after Cold compression and TYLENOL Drops.
Red, spotty rash starting out light and small day of vaccines and growing increasingly darker and larger over the week. Rash started on torso and spread throughout body to legs, arms, feet and some on the face. Required Benadyl prescription
after the second shot in the middle of the night I had severe pains in my left arm in the area near a Lipoma; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 82 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 82 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: HTZ; LEVOTHYROXINE. Past drug history included: Cipro, reaction(s): "known allergies Cipro"; Prolia, reaction(s): "known allergies: Prolia"; Risedronate, reaction(s): "known allergies Risedronate". Vaccination history included: Bnt162b2 (administration time=06:30 AM,, vaccine location=Right arm,, dose number=1), administration date: 17Feb2021, when the patient was 82 years old, for COVID-19 immunisation, reaction(s): "vertigo", "dizziness".  The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "after the second shot in the middle of the night I had severe pains in my left arm in the area near a Lipoma". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reporting event roughly 6-8 weeks after Pfizer Covid booster shot. For reference, the first two vaccine doses were as follows: 1st dose: 04/09/2021  Lot EN6203   2nd dose: 04/30/2021  Lot EP6955 As reported on this form, booster was administered on 11/05/2021 Symptoms of what was believed to be Covid 19 began on 01/02/2022- sore throat, fever of 101-103, extreme tiredness and achiness.  Produced a negative Covid test on 01/06/2022.  Family heard from on 01/13/2022 when he reported feeling some better to his mother, but was experiencing some dizziness and had knocked over and broken some things in his apartment (lived alone.)  This was attributed to his illness and being light-headed after getting up too soon.  Found unresponsive on 01/15/2022 and transported to hospital where he ultimately died.  Before he passed, he was found to have suffered multiple strokes probably in the weeks/days prior, and suffered a massive stroke in the 12-24 hours before being found unresponsive.  His platelets were also reported to be extremely low and he had atrial fibrillation.
On 7-9-2022, I started having fatigue and a cough. On 7-12, I noticed I was sneezing alot. I tested with a home Covid19 test on 7-14 with positive results. I called my healthplan who set me up with a doctor for a telehealth visit  for 7-15. The doctor prescribed Paxlovid on 7-15 and I began taking it that day. I am feeling great now. I am reporting a breakthru case of Covid19.
the patient was administered lhe first dose of GARDASIL 9 on 12-FEB-2020 and fainted while in the office; Information has been received from a nurse via filed representative, referring to a 14 years old female patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 12-FEB-2020, the patient was administered the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength and dose detail were not reported) (lot # R029507, expiration date 10-JUL-2021) intramuscularly for prophylaxis.  On the same date after receiving the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), the patient fainted while in the office. The patient was given treatment with crackers and water. The outcome of faint was recovered and the patient was able to go home shortly after fainting. The causality assessment was not provided.  Upon internal review, faint was determined to be medically significant.
Mother reported to this provider that after patient received 2 month vaccines, patient developed fever within 24 hours. Max at 105 degrees -> ER for evaluation.
Muscle pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain). At the time of the report, MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitants included. No Treatment was included.
Patient stated he has fainted before with vaccines & blood draws prior to him receiving the J&J vaccine. After I gave him the vaccine, he asked me if he could lay down on the ground because he was feeling lightheaded. I kept the pharmacy door open so we can monitor him while he was on the ground. He was doing fine until he decided to get back up after about 5 minutes to have a seat outside our waiting room. Less than a minute after he sat down on the chair, patient fainted on the chair. I ran outside to try to wake him up & told my technicians to call EMT. Patient wasn't responsive for about 1-2 minutes, EMT arrived about 5-10 minutes later. Patient refused to go to hospital and had a family member / friend drive him home. Patient was advise by EMT to call them if anything else happens after getting home.